54325 recent Wall Street rating changes — with our own star rating shown next to every analyst we independently track.
Track the latest analyst rating changes from Wall Street brokerages: stock upgrades, downgrades and price-target revisions, updated through the day. Unlike a plain ratings feed, every change here is matched — where we can — to the analyst's independent track record on 13Foresight, so you can see at a glance whether the person behind the call has actually been accurate. Analysts we rank show a ★★★★☆ score and link to their full performance page; firms link to their pooled track record. Use the tabs below to filter by change type.
| When | Stock | Change | Analyst | Rating | Price Target |
|---|---|---|---|---|---|
|
Aug 06
19:31 UTC
|
BAM
Brookfield Asset Management
|
◎ Target | firm only | Sec→ r Outperform | $57.00→ $59.00+3.5% |
|
Aug 06
19:31 UTC
|
BAM
Brookfield Asset Management
|
◎ Target | firm only | Neutral | $48.00→ $55.00+14.6% |
|
Aug 06
19:31 UTC
|
AXON
Axon Enterprise
|
◎ Target | Andrew Spinola ★★★☆☆ #1636 | Neutral | $440.00→ $600.00+36.4% |
|
Aug 06
19:31 UTC
|
ARWR
Arrowhead Pharmaceuticals
|
◎ Target | Patrick R. Trucchio not yet tracked | Buy | $115.00→ $120.00+4.3% |
|
Aug 06
19:31 UTC
|
AMPL
Amplitude
|
◎ Target | Taylor McGinnis ★★★★★ #28 | Buy | $8.50→ $13.00+52.9% |
|
Aug 06
19:31 UTC
|
AHCO
AdaptHealth
|
◎ Target | Kevin Caliendo ★★★★☆ #545 | Buy | $14.00→ $10.00-28.6% |
|
Aug 06
19:31 UTC
|
ADNT
Adient
|
◎ Target | Joseph Spak ★★★☆☆ #1858 | Buy | $34.00→ $29.00-14.7% |
|
Aug 06
19:31 UTC
|
ADEN
ADENTRA
|
◎ Target | firm only | Buy | C$43.00→ C$46.00+7.0% |
|
Aug 06
19:31 UTC
|
PRL
Propel
|
↑ Upgrade | firm only | Outperform→ Strong-Buy | C$31.00→ C$38.00+22.6% |
|
Aug 06
19:31 UTC
|
FA
First Advantage
|
↑ Upgrade | Kyle Peterson ★★★☆☆ #1696 | Hold→ Buy | $28.00 |
|
Aug 06
18:31 UTC
|
VYX
NCR Voyix
|
◎ Target | Daniel Perlin ★★★★☆ #380 | Outperform | $10.00→ $13.00+30.0% |
|
Aug 06
18:31 UTC
|
VVV
Valvoline
|
◎ Target | Steven Shemesh ★★★★☆ #788 | Outperform | $47.00→ $46.00-2.1% |
|
Aug 06
18:31 UTC
|
VOYA
Voya Financial
|
◎ Target | Kenneth Lee ★★★★☆ #402 | Outperform | $107.00→ $110.00+2.8% |
|
Aug 06
18:31 UTC
|
UTHR
United Therapeutics
|
◎ Target | Lisa Walter ★★☆☆☆ #2744 | Outperform | $704.00→ $677.00-3.8% |
|
Aug 06
18:31 UTC
|
UBER
Uber Technologies
|
◎ Target | Ken Gawrelski ★★★☆☆ #1182 | Overweight | $100.00→ $89.00-11.0% |
|
Aug 06
18:31 UTC
|
TRI
Thomson Reuters
|
◎ Target | Drew McReynolds ★★★☆☆ #1868 | Outperform | $121.00→ $124.00+2.5% |
|
Aug 06
18:31 UTC
|
TPR
Tapestry
|
◎ Target | Dana Telsey ★★★☆☆ #991 | Outperform | $160.00→ $175.00+9.4% |
|
Aug 06
18:31 UTC
|
TLN
Talen Energy
|
◎ Target | Shahriar Pourreza ★★★☆☆ #1543 | Overweight | $482.00→ $501.00+3.9% |
|
Aug 06
18:31 UTC
|
TDUP
ThredUp
|
◎ Target | Dana Telsey ★★★☆☆ #991 | Outperform | $7.00→ $6.00-14.3% |
|
Aug 06
18:31 UTC
|
SNDK
Sandisk
|
◎ Target | Aaron Rakers ★★★☆☆ #1588 | Equal Weight | $1,620.00→ $1,400.00-13.6% |
|
Aug 06
18:31 UTC
|
SNDK
Sandisk
|
◎ Target | Srini Pajjuri ★★☆☆☆ #2445 | Sec→ r Perform | $1,000.00→ $1,300.00+30.0% |
|
Aug 06
18:31 UTC
|
SHAK
Shake Shack
|
◎ Target | Steve McManus not yet tracked | Outperform | $77.00→ $81.00+5.2% |
|
Aug 06
18:31 UTC
|
SEDG
SolarEdge Technologies
|
◎ Target | Christopher Dendrinos not yet tracked | Sec→ r Perform | $30.00→ $24.00-20.0% |
|
Aug 06
18:31 UTC
|
RVMD
Revolution Medicines
|
◎ Target | Leonid Timashev ★★★☆☆ #1391 | Outperform | $182.00→ $203.00+11.5% |
|
Aug 06
18:31 UTC
|
RCUS
Arcus Biosciences
|
◎ Target | Eva Fortea Verdejo ★★★★☆ #917 | Equal Weight | $23.00→ $26.00+13.0% |
|
Aug 06
18:31 UTC
|
PSX
Phillips 66
|
◎ Target | Sam Margolin ★★★★☆ #754 | Overweight | $201.00→ $239.00+18.9% |
|
Aug 06
18:31 UTC
|
PODD
Insulet
|
◎ Target | Shagun Singh not yet tracked | Outperform | $245.00→ $160.00-34.7% |
|
Aug 06
18:31 UTC
|
PINS
Pinterest
|
◎ Target | Alec Brondolo ★★★☆☆ #1228 | Overweight | $30.00→ $31.00+3.3% |
|
Aug 06
18:31 UTC
|
PACS
PACS Group
|
◎ Target | Ben Hendrix ★★★★☆ #740 | Outperform | $52.00→ $57.00+9.6% |
|
Aug 06
18:31 UTC
|
NNN
NNN REIT
|
◎ Target | Brad Heffern ★★★★☆ #362 | Sec→ r Perform | $44.00→ $47.00+6.8% |
|
Aug 06
18:31 UTC
|
NAMS
NewAmsterdam Pharma
|
◎ Target | Leonid Timashev ★★★☆☆ #1391 | Outperform | $51.00→ $50.00-2.0% |
|
Aug 06
18:31 UTC
|
MNKD
MannKind
|
◎ Target | Benjamin Burnett ★★★☆☆ #1802 | Overweight | $14.00→ $13.00-7.1% |
|
Aug 06
18:31 UTC
|
MIRM
Mirum Pharmaceuticals
|
◎ Target | Lisa Walter ★★☆☆☆ #2744 | Outperform | $148.00→ $135.00-8.8% |
|
Aug 06
18:31 UTC
|
MGNI
Magnite
|
◎ Target | Matthew Swanson ★★★☆☆ #1014 | Outperform | $20.00→ $27.00+35.0% |
|
Aug 06
18:31 UTC
|
MDLN
Medline
|
◎ Target | Ryan Halsted ★★★★★ #302 | Outperform | $53.00→ $46.00-13.2% |
|
Aug 06
18:31 UTC
|
LLY
Eli Lilly and Company
|
◎ Target | Mohit Bansal ★★★☆☆ #1220 | Overweight | $1,280.00→ $1,330.00+3.9% |
|
Aug 06
18:31 UTC
|
KVYO
Klaviyo
|
◎ Target | Ryan MacWilliams ★★★★★ #303 | Overweight | $26.00→ $22.00-15.4% |
|
Aug 06
18:31 UTC
|
IRM
Iron Mountain
|
◎ Target | Eric Luebchow ★★☆☆☆ #2766 | Overweight | $135.00→ $140.00+3.7% |
|
Aug 06
18:31 UTC
|
HUBS
HubSpot
|
◎ Target | Rishi Jaluria ★★★☆☆ #1145 | Outperform | $350.00→ $300.00-14.3% |
|
Aug 06
18:31 UTC
|
HONA
Honeywell Aerospace
|
◎ Target | Ken Herbert not yet tracked | Outperform | $300.00→ $250.00-16.7% |
|
Aug 06
18:31 UTC
|
HONA
Honeywell Aerospace
|
◎ Target | Matthew Akers ★★★★★ #238 | Neutral | $245.00→ $210.00-14.3% |
|
Aug 06
18:31 UTC
|
GSL
Global Ship Lease
|
◎ Target | Stephanie Moore ★★☆☆☆ #2763 | Buy | $45.00→ $50.00+11.1% |
|
Aug 06
18:31 UTC
|
FLUT
Flutter Entertainment
|
◎ Target | Trey Bowers ★★★☆☆ #1439 | Equal Weight | $137.00→ $112.00-18.2% |
|
Aug 06
18:31 UTC
|
CRTO
Criteo
|
◎ Target | Brian Nowak ★★☆☆☆ #2551 | Equal Weight | $29.00→ $25.00-13.8% |
|
Aug 06
18:31 UTC
|
CRCL
Circle Internet Group
|
◎ Target | James Faucette ★★★☆☆ #1134 | Underweight | $38.00→ $37.00-2.6% |
|
Aug 06
18:31 UTC
|
CPAY
Corpay
|
◎ Target | Daniel Perlin ★★★★☆ #380 | Sec→ r Perform | $363.00→ $423.00+16.5% |
|
Aug 06
18:31 UTC
|
CMPS
Compass Pathways
|
◎ Target | Leonid Timashev ★★★☆☆ #1391 | Outperform | $22.00→ $21.00-4.5% |
|
Aug 06
18:31 UTC
|
CMPS
Compass Pathways
|
◎ Target | Judah Frommer ★★★☆☆ #1634 | Overweight | $17.00→ $18.00+5.9% |
|
Aug 06
18:31 UTC
|
CHYM
Chime Financial
|
◎ Target | James Faucette ★★★☆☆ #1134 | Overweight | $31.00→ $33.00+6.5% |
|
Aug 06
18:31 UTC
|
CE
Celanese
|
◎ Target | Michael Sison ★★★☆☆ #2197 | Overweight | $80.00→ $65.00-18.8% |
An analyst rating change is when a Wall Street brokerage updates its recommendation on a stock — an upgrade (e.g. Hold → Buy), a downgrade (e.g. Buy → Sell), or a price-target revision (raising or lowering the expected share price). This page lists the most recent changes across U.S. markets.
Where we independently track the analyst, each change shows our own star rating and accuracy rank, computed from real historical price performance — not the brokerage's own marketing. That lets you judge whether the analyst behind a call has actually been right before.
The feed refreshes several times a day, so new upgrades, downgrades and price-target changes appear the same day they are published. Each row shows the date and time we recorded it.
No. A rating change is one analyst's opinion, not investment advice. Track records vary widely — which is exactly why we attach each analyst's independent accuracy. Always do your own research.